Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1086 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-18

Study Completion Date

2027-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if the intervention of delivery of antiretroviral drugs by medical drones can improve virological suppression in a fisherfolk community population living with HIV in the islands of Kalangala District, Uganda. The main question it aims to answer is:

Can delivery of anti-retroviral therapy (ART) by unmanned aerial vehicles (medical drones) to people living with HIV (PLHIV) improve virological outcomes compared to the standard of care (SOC) in an underserved population? Primary hypothesis: The investigators hypothesize that using drones will increase viral suppression in those receiving the intervention as compared to the control or outcome measure one-will be the proportion of PLHIV with undetectable HIV viral load in the intervention (drones) versus SOC arm at 12 months.

If there is a comparison group: Researchers will compare \[Medical Drones delivery group\] to see total cost of 12 months medication delivery to people living with HIV (PLHIV) in the intervention as compared to standard of care (SOC) arm.

Proportion PLHIV with an undetectable viral load at 6, 18 and 24 months in intervention Rates of retention in care of PLHIV at 6,12, 18 and 24 months in intervention as compared to SOC arm

* Participants will be seen every 6 months for 24 months
* They will have blood draws for viral load tests
* They will complete interviewer administered questionnaires
* The intervention is last-mile delivery of ART by drones to landing sites

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Facility and Home-based ART Delivery Systems in Uganda

NCT00144365

AIDS

COMPLETED PHASE3

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

NCT00078247

HIV Infections Tuberculosis

COMPLETED PHASE3

Early HIV Therapy in Patients With High CD4 Cell Counts

NCT01479634

HIV

COMPLETED NA

The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression

NCT02711293

HIV Community Health Workers Antiretroviral Therapy, Highly Active

COMPLETED NA

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

NCT02028676

Human Immunodeficiency Virus

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Investigators will undertake a cluster randomised trial of the efficacy of medical drone use by randomization of health facilities and their associated landing sites in Kalangala District. There are 64 landing sites and 18 health facilities. The unit of radomisation will be the landing site, so that all persons at one landing site will receive the drone delivery or boat delivery, facility pick-up. This will avoid contamination of drone delivery by sharing of ART between people getting drone and boat or other modes of deliveries. Bias in this situation will be managed by stratifying the landing sites by distance from drone operations base (a proxy of delivery cost), and number of differentiated service delivery (DSD) groups. Bias in gender and age will be managed at selection of members in DSD groups. We will also undertake a cost effectiveness analysis, carbon analysis and process evaluation. A qualitative study will assess acceptability and additional use cases

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Viral Load

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Cluster randomised trial using a non-inferiority design

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Arm

Delivery of ART by fixed wing drones to landing sites

Group Type EXPERIMENTAL

Fixed Wing drones

Intervention Type DEVICE

Last Mile fixed wing drone delivery

Control arm

Usual ART delivery to landing sites

Group Type ACTIVE_COMPARATOR

No Drone delivery

Intervention Type DEVICE

Usual ART delivery to landing sites

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Drone delivery

Usual ART delivery to landing sites

Intervention Type DEVICE

Fixed Wing drones

Last Mile fixed wing drone delivery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (\>18 years) living with HIV
* Emancipated minor (15-17 years) who is living with HIV
* Receiving antiretroviral therapy in Kalangala District
* Be a resident in Kalangala district for at least the preceding 6-12 months
* Willing to stay for a minimum next 24 months
* Willing to disclose HIV status to an expert peer or village health team member.
* Willing to join discentralised Service Delivery model groups

Exclusion Criteria

* Potential participants below 15 years with care providers not receiving care from DSD.
* No active opportunistic infection (including but not limited to TB) in health centre records or self-report or suspected by the study team at enrolment (will be referred back to health facility for investigations and can be enrolled if no infection confirmed).
* Patients with mental illness or any other medical condition that compromises decision making process (as determined by medical records at facility and direct questioning to participant)
* Any other clinical condition that, in the opinion of the site investigator, would make the participant unsuitable for the study or unable to comply with dosing requirements.
* For stage three, participants residing in areas that took part in stage 2 drone delivery eg Bufumira island

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No